CIK 0001623526 · Non-accelerated filer<br>Smaller reporting company
Stoke Therapeutics, Inc.
Sign in to watch- Ticker
- STOK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 471144582
- Phone
- 781-430-8200
- Business address
- 45 WIGGINS AVENUE, BEDFORD, MA, 01730
- Former names
- ASOthera Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,050,832
- in 7 filings, $404K under 10b5-1 plans
Net −$1,050,832. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-02 | Ticho Barry CHIEF MEDICAL OFFICER | Sale 10b5-1 | −6,995 | $26.38 | $185K | 12,064 |
| 2026-11-02 | Ticho Barry CHIEF MEDICAL OFFICER | Sale 10b5-1 | −200 | $26.99 | $5K | 11,864 |
| 2026-10-02 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Sale 10b5-1 | −627 | $26.33 | $17K | 20,598 |
| 2026-10-01 | Ticho Barry CHIEF MEDICAL OFFICER | Sale 10b5-1 | −1,051 | $26.16 | $27K | 19,059 |
| 2026-09-23 | Cumbo Alexander Director | Grant or award · Director Stock Option (Right to Buy) | +39,674 | 39,674 | ||
| 2026-09-01 | Ticho Barry CHIEF MEDICAL OFFICER | Sale 10b5-1 | −3,945 | $30.51 | $120K | 21,710 |
| 2026-09-01 | Ticho Barry CHIEF MEDICAL OFFICER | Sale 10b5-1 | −1,600 | $31.06 | $50K | 20,110 |
| 2026-08-18 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Sale | −2,716 | $32.01 | $87K | 21,370 |
| 2026-08-18 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Sale | −145 | $32.47 | $5K | 21,225 |
| 2026-08-18 | Ticho Barry CHIEF MEDICAL OFFICER | Sale | −4,525 | $32.01 | $145K | 25,897 |
| 2026-08-18 | Ticho Barry CHIEF MEDICAL OFFICER | Sale | −242 | $32.47 | $8K | 25,655 |
| 2026-08-18 | Kaye Edward M. MD Director | Sale | −11,930 | $32.01 | $382K | 125,194 |
| 2026-08-18 | Kaye Edward M. MD Director | Sale | −637 | $32.47 | $21K | 124,557 |
| 2026-08-14 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Option exercise | +6,000 | 24,086 | ||
| 2026-08-14 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Option exercise · Performance Stock Units | −6,000 | 0 | ||
| 2026-08-14 | Ticho Barry CHIEF MEDICAL OFFICER | Option exercise | +10,000 | 30,422 | ||
| 2026-08-14 | Ticho Barry CHIEF MEDICAL OFFICER | Option exercise · Performance Stock Units | −10,000 | 0 | ||
| 2026-08-14 | Kaye Edward M. MD Director | Option exercise | +26,250 | 137,124 | ||
| 2026-08-14 | Kaye Edward M. MD Director | Option exercise · Performance Stock Units | −26,250 | 0 | ||
| 2026-08-03 | Ticho Barry CHIEF MEDICAL OFFICER | Sale 10b5-1 | −5,907 | $28.95 | $171K | 21,691 |
Page 1 of 13 · 256 trades